Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Fluad and Fluzone Influenza Vaccines in Children 6 to <60 Months
2014-004543-12Phase 2
- Sponsor
- Novartis
- Start
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Fluzone Trivalent in influenza (4 arms), sponsored by Novartis. Primary endpoint: Local or systemic reactions within 1–7 days after vaccination.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-004543-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004543-12.